A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
Clinical trial NCT05493995 · COMPLETED
Trial details
- NCT number
- NCT05493995
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2024-05-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.